Mounjaro®
Starting from £179.99/mo
Start journey Learn moreComparing Wegovy prices in the UK is harder than it looks. Private providers set their own fees, those fees vary by dose, and what appears in a headline figure often leaves out prescription costs, delivery, or ongoing clinical support. Wegovy (semaglutide) is a prescription-only medicine — a prescriber has to assess you before any treatment can be dispensed, and that assessment should be part of what you're paying for, not an afterthought. Our guide to Wegovy in the UK covers the basics of how the medicine works if you're still at that stage; this page focuses on what price comparisons across private providers actually reveal.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer: providers are pricing different things. Wegovy's licensed starting dose is 0.25mg, titrated upward over several months toward a 2.4mg maintenance dose — and some services price each pen individually, others by monthly supply, others as a bundle. A 0.25mg pen naturally costs less than a 2.4mg pen, so comparing two providers quoting different doses gives a misleading picture. Our UK Wegovy price comparison page lays this out dose by dose.
There's also the Novo Nordisk supply picture to factor in. Wegovy was in intermittent shortage for much of 2023 and 2024; pricing responded to availability. Since then, supply has stabilised and the 7.2mg dose received MHRA approval in April 2026 (a single-dose pen for eligible adults) which adds another tier to any comparison, and you can see how the 1.7mg step fits into that picture on our Wegovy 1.7mg price comparison page. A fair like-for-like means matching dose, pen format, and what the fee actually includes. If that last part isn't listed plainly on the provider's site, that's worth noticing.
For context on the semaglutide landscape more broadly, the semaglutide price comparison page covers how Wegovy pricing sits relative to other semaglutide-based options in the UK private market.
This is the question a price comparison rarely answers clearly. A headline monthly figure might cover the medicine itself but treat the prescription, delivery, and any follow-up support as separate line items. Some providers charge a consultation fee before you know whether they'll prescribe at all. Others add a delivery charge per dispatch or require a paid membership to access clinical support between doses.
Common extras to check for: a fee to transfer your prescription if you move providers, a charge for dose-increase reviews, or a subscription that auto-renews unless you cancel. None of those are unreasonable business models, but they change the actual monthly cost considerably once you're on a higher dose that needs reviewing every four weeks. The 2.4mg Wegovy price comparison is particularly useful here, because that's the maintenance dose most people reach and the one where ongoing review costs start to matter.
At nume, one price covers the consultation, the prescription, the medicine and next-working-day tracked delivery. There are no subscriptions and no auto-renewals. Every repeat order is reviewed again by a prescriber before it goes out, that's not a premium add-on, it's just how a responsible pharmacy works.
Honestly? We're not the cheapest option you'll find. That's a deliberate choice, not an oversight. A GPhC-registered Independent Prescriber reads every consultation (not a triage algorithm) on the same day it arrives. Photo-ID verification and live weight confirmation happen before any medicine is dispensed. Your GP is notified in line with GPhC guidance. Those steps cost more to run than a purely automated pathway, and we think the tradeoff is obvious for a prescription medicine.
What you're comparing, then, isn't really pen A against pen B at two different prices. It's a full clinical service against a dispensing-only model, or sometimes against an unverified seller you found via a social media advert. For a sense of what a well-run private consultation looks like from the clinical side, you can read more about our clinical team. If you want to check what the current treatment pricing at nume looks like, it's all on the treatment page with nothing held back.
Not automatically, but it's always a question worth asking. The MHRA has issued repeated warnings about counterfeit weight-loss pens sold online, and enforcement in 2025 uncovered approximately 20 million doses of illegally traded medicines worth around £45 million, including a UK site producing counterfeit tirzepatide pens. Fake pens have previously been found to contain insulin rather than the labelled medicine, which can be genuinely dangerous.
The clearest safety check available to any UK patient: verify that the pharmacy dispensing your medicine is registered with the GPhC at pharmacyregulation.org. Prices far below the market range, sellers operating via Instagram or WhatsApp, and offers of Wegovy without any clinical assessment are all patterns the MHRA flags as warning signs, you can report suspect sellers at yellowcard.mhra.gov.uk. For a prescription medicine, the question isn't just what's cheapest. It's what's legitimate, what's safe, and what includes the clinical oversight that actually protects you over the months you're on treatment. The 1mg Wegovy price comparison page goes into more detail on what to look for at that specific dose.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.